Overview

A Pharmacokinetic Study of Oral Deflazacort in Children and Adolescent Subjects With Duchenne Muscular Dystrophy

Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
Study to characterize the single-state and steady-state dosing of oral deflazacort in pediatric and adolescents subjects.
Phase:
Phase 1
Details
Lead Sponsor:
Marathon Pharmaceuticals, LLC
PTC Therapeutics
Treatments:
Deflazacort